RenovoRx Inc reports results for the quarter ended in December - Earnings Summary

RenovoRx

01/04/2024 23:14

* RenovoRx Inc  RNXT.OQ  reported a quarterly adjusted loss
of 31
cents​​ per share for the quarter ended in December, lower than
the same quarter last year, when the company reported EPS of -23
cents.  The mean expectation of three analysts for the quarter
was for a loss of 30 cents per share. Wall Street expected
results to range from -31 cents to -30 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * RenovoRx Inc's reported EPS for the quarter was a loss
of 31
cents​.
    * The company reported a quarterly loss of $3.23 million.
    * RenovoRx Inc shares had held steady so far this
quarter and
lost 41.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for RenovoRx Inc is
$4.00 
This summary was machine generated from LSEG data April 1 at
10:14 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.30          -0.31          Missed
 Sep. 30 2023      -0.30          -0.13          Beat
 Jun. 30 2023      -0.25          -0.31          Missed
 Mar. 31 2023      -0.25          -0.36          Missed